Coronavirus Disease-19 in a patient with minimal change nephrotic syndrome undergoing rituximab monotherapy

Saudi J Kidney Dis Transpl. 2021 Sep-Oct;32(5):1505-1506. doi: 10.4103/1319-2442.344780.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • Female
  • Humans
  • Immunologic Factors
  • Male
  • Nephrosis, Lipoid* / complications
  • Nephrosis, Lipoid* / diagnosis
  • Nephrosis, Lipoid* / drug therapy
  • Nephrotic Syndrome* / diagnosis
  • Nephrotic Syndrome* / drug therapy
  • Recurrence
  • Rituximab / therapeutic use
  • Treatment Outcome

Substances

  • Immunologic Factors
  • Rituximab